OOIR: Observatory of International Research

Papers

(The median citation count of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
3136 – LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS	61
3077 – FUNCTIONAL AND MOLECULAR IDENTIFICATION OF A FETAL-ASSOCIATED TUMOR SUPPRESSOR AXIS: ABROGATION OF MLL-ENL DRIVEN ACUTE MYELOID LEUKEMIA	44
3054 – CROSSTALK AT THE MATERNAL-FETAL INTERFACE CONSTRAINS FETAL HEMATOPOIETIC STEM AND PROGENITOR CELL RESPONSE TO INFLAMMATION.	28
3010 – REJUVENATING BLOOD STEM CELLS EXTENDS LIFESPAN OF AGED IMMUNOCOMPROMISED MICE	24
3163 – MODULATION OF RNA POLYMERASE II ACTIVITY REGULATES HUMAN HSC SELF-RENEWAL	22
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.	21
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO	20
3219 – RNA DEADENYLATION SUBUNIT CNOT3 PROMOTES MYELOID LEUKEMIA BY DRIVING TRANSLATION OF ONCOGENIC TARGETS	19
1022 – GENE THERAPY FOR BETA-THALASSEMIA: FROM THE BENCH TO THE BEDSIDE AND BACK	18
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS	18
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING	18
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION	17
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS	17
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS	17
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE	16
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]	16
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE	15
Corrigendum to <‘Novel therapeutic strategies for multiple myeloma’> <[Experimental Hematology 2015; 43: 732-741]>	15
IFC Editorial Board	15
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION	14
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN	13
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs	12
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e5	12
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA	12
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes	11

Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage	11
3065 – CRISPR MODELING OF ACUTE MYELOID LEUKEMIA MUTATIONS IN PRIMARY HEMATOPOIETIC STEM CELLS TO STUDY (PRE-)LEUKEMIA DEVELOPMENT	11
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL	11
RNA methylation: where to from here for hematologic malignancies?	11
3114 – FROM MECHANISMS OF LEUKAEMOGENIC DYSREGULATION TO NEW CANDIDATE THERAPEUTICS	11
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis	11
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA	11
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS	11
2019 – SYSTEMIC AND LOCAL REGULATION COOPERATES TO DETERMINE HEMATOPOIETIC STEM CELL NUMBERS	10
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS	10
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION	10
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION	10
3040 – DRUG DISCOVERY FOR INHIBITORS OF PHAGOCYTOSIS FOR USE IN IMMUNE CYTOPENIAS	10
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT	10
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES	10
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY	10
3006 – JAK2 PHOSPHORYLATES THE RNA PROCESSING PROTEIN HNRNPA1 TO REPRESS THE EXPRESSION OF RETROTRANSPOSONS AND PROTECT THE HAEMATOPOIETIC STEM CELL GENOME	10
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS	10
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION	10
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL1	10
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW	9
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)	9
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA	9
Cover 2: Editorial Board	9
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms	8
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment	8
Integrins and their role in megakaryocyte development and function	8
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing	8
Macrophages form erythropoietic niches and regulate iron homeostasis to adapt erythropoiesis in response to infections and inflammation	8
Building bones for blood and beyond: the growing field of bone marrow niche model development	8
A new era of functional experimentation in human hematopoiesis and leukemia research	8
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming	8
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis	7
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy	7
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia	7
3056 – VITAMIN C LIMITS MULTIPOTENT PROGENITOR SELF-RENEWAL AND CLONAL EXPANSION	7
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis	7
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes	7
3104 – TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF MURINE FETAL LIVER HEMATOPOIETIC STEM CELLS AT SINGLE CELL RESOLUTION	7
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period	7
Cover 2: Editorial Board	7
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience	7
3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA	7
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION	6
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS	6
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION	6
3119 – DECIPHERING THE IMPACT OF TYPE 1 INTERFERON IN HUMAN CALR-MUTATED AND WILDTYPE HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELOPROLIFERATIVE NEOPLASMS VIA SINGLE-CELL MULTI-OMICS	6
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING	6
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES	6
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY	6

1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS	6
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS	6
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL	6
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES	6
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA	5
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells	5
3209 – SINGLE-CELL PROFILING OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS A GRADUAL TRANSITION FROM PRE-LEUKEMIA TO LEUKEMIA	5
Immune control in acute myeloid leukemia	5
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS	5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE	5
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)	5
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis	5
3210 – BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 (CP1) IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)	5
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes	5
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.	5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL	5
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL	5
3215 – A SINGLE-CELL EXPRESSION ATLAS OF HUMAN AML LEUKEMIA-INITIATING CELLS UNRAVELS THE CONTRIBUTION OF HIF PATHWAY AND ITS THERAPEUTIC POTENTIAL	5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro	5
3204 – NK CELL-DEFECTS OCCURRING ALREADY AT THE PRE-MDS STAGE IN NUP98-HOXD13 TRANSGENIC MOUSE MODEL	5
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study	5
3222 – THE SURROGATE HEMATOPOIETIC STEM CELL NICHE AS A TOOL TO UNDERSTAND HEMATOPOIETIC STEM CELL EXPANSION	5
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV	5
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY	4
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS	4
Development and aging of resident endothelial stem cells in pre-existing blood vessels	4
3060 – PDGFRΒ+ CELLS PLAY A DUAL ROLE AS HEMATOPOIETIC PRECURSORS AND NICHE CELLS DURING MOUSE ONTOGENY	4
3002 – CIRCADIAN CUES REPROGRAM METABOLIC PATHWAYS IN LONG-TERM REPOPULATING HEMATOPOIETIC STEM CELLS	4
3090 – CLONAL RECONSTRUCTION FROM CO-OCCURRENCE OF VECTOR INTEGRATION SITES ALLOWS ACCURATE QUANTIFICATION OF EXPANDING CLONES IN VIVO	4
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs	4
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.	4
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION	4
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA	4
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA	4
2022 – CHARACTERIZING HETEROGENEITY IN HEALTHY AND MALIGNANT HEMATOPOIETIC HIERARCHIES USING SINGLE CELL PROTEOMICS	4
3093 – SUBTYPE-SPECIFIC INDUCTION OF MITOCHONDRIAL APOPTOSIS AS A NOVEL THERAPEUTIC OPTION IN HIGH-FATALITY PEDIATRIC LEUKEMIA	4
Short Talk Presentations	4
3074 – GLOBAL EPIGENOMIC REGULATION OF GENE EXPRESSION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY IKAROS	4
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS	4
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS	4
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia	4
3048 – MECHANISMS AND PROGNOSIS OF A20 MUTATION AND ABNORMAL EXPRESSION IN T-CELL MALIGNANCIES	4
3041 – CELLULAR MECHANISMS INVOLVED IN SERONEGATIVE HEMOLYTIC ANEMIAS	4
3057 – HIGH SALT DIETS PROMOTE A TH17 CELL DRIVEN GUT-BONE AXIS TO REGULATE HAEMATOPOIESIS AND ATHEROSCLEROSIS	4
Functional and molecular profiling of hematopoietic stem cells during regeneration	4
Fetal allotransplant recipients are resistant to graft-versus-host disease	3
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES	3
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE	3
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS	3
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION	3
1032 – STEM CELLS IN HUMAN AML	3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells	3
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells	3
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils	3
3203 – IDENTIFICATION OF DIFFERENTIATION ROOTS OF HEMATOPOIETIC STEM CELLS BY A PAIRED-DAUGHTER ASSAY COMBINED WITH MULTIPLE BARCODING	3
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS	3
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS	3
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY	3
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells	3
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING	3
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT	3
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS	3
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia	3
Assay optimization for the objective quantification of human multilineage colony-forming units	3
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION	3
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT	3
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization	3
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION	3
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA	3
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies	3
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent	3
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy	3
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice	3
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT	2
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR	2
3232- – INFLAMMATORY STRESS PROMOTES HETEROGENEOUS ACTIVATION OF IMMUNE RESPONSE PROGRAMS IN HUMAN HEMATOPOIETIC STEM CELLS	2
2001 – THE ENDOSOMAL ADAPTOR PROTEIN MYCT1 CONTROLS ENVIRONMENTAL SENSING IN HUMAN HEMATOPOIETIC STEM CELLS	2
Cover 2: Editorial Board	2
3021 – SINGLE-CELL RNASEQ REVEALS CELL ADHESION MOLECULE PROFILES OF SHORT-TERM AND LONG-TERM CORD BLOOD HEMATOPOIETIC STEM CELLS	2
3184 – ONCOSTATIN M SIGNALING MEDIATES DNMT3A-MUTANT HEMATOPOIETIC STEM CELL FITNESS IN THE AGED BONE MARROW MICROENVIRONMENT	2

1018 – HETEROGENEITY AND FUNCTIONAL SPECIALIZATION OF THE BONE MICROVASCULATURE	2
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA	2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.	2
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer	2
The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis	2
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS	2
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia	2
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION	2
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS	2
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS	2
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND	2
3061 – STROMAL CELL-TRIGGERED DOWNREGULATION OF THE NUCLEOPORIN (NUP) FAMILY DRIVES TRANSFORMATION OF MYELODYSPLASIA TO ACUTE MYELOID LEUKEMIA	2
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS	2
3148 – GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS	2
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING	2
3051 – HEMATOPOIETIC STEM CELLS DEPEND ON AUTOPHAGY TO MAINTAIN PROTEIN HOMEOSTASIS	2
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)	2
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells	2
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS	2
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis	2
3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA	2
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL	2
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION	2
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	2
1023 – THE IMPORTANCE OF STEM CELL EXPANSION IN TOMORROW'S MEDICINE	2
From Metcalf to myeloproliferative neoplasms – a personal journey	2
3081 – LCK DRUG TARGETING IN PAX5 REARRANGED CASES IN POOR RISK CHILDHOOD B-CELL PRECURSORS ACUTE LYMPHOBLASTIC LEUKAEMIA	2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone	2
3106 – GENOME-WIDE CRISPR SCREENING IDENTIFIES THE E3 UBIQUITIN LIGASE HERC1 AS A MODULATOR OF THE RESPONSE TO NUCLEOSIDE ANALOGS IN ACUTE MYELOID LEUKEMIA	2
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche	2
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS	2
3037 – POLYCOMB GROUP PROTEIN MEL18 REGULATES HEMATOPOIETIC STEM CELL BEHAVIORS VIA MODULATING THE EPIGENOME AND HIGHER ORDER CHROMATIN STRUCTURE	2
A-to-I RNA editing and hematopoiesis	2
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT	2
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL	2
3221 – INVESTIGATING THE ROLE OF UBIQUITIN E3 LIGASE, FBXO21, IN THE REGULATION OF CYTOKINE SIGNALING WITHIN ACUTE MYELOID LEUKEMIA	2
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS	2
Cover 2: Editorial Board	1
3126 – PERSISTENT METABOLIC DEFLATION OF HEMATOPOIETIC STEM CELLS (HSCS) AFTER CHEMOTHERAPY CAUSES PREMATURE HEMATOPOIETIC AGEING	1
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	1
3181 – CRISPR/CAS9-MEDIATED CORRECTION OF FANCC GENE RESCUES THE INDUCED BONE MARROW FAILURE IN FANCC-/- MOUSE	1
3192 – CASPASE-1 AFFECTS ACTIVATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AFTER CHEMOTHERAPY	1
FT-4202, a selective pyruvate kinase R activator for sickle cell disease	1
Amyloid deposition through endocytosis in vascular endothelial cells	1
2005 – IL13/IL4 CONTRIBUTES TO FIBROTIC PROGRESSION OF THE MYELOPROLIFERATIVE NEOPLASMS	1
3104 – EARLY MOLECULAR STEPS IN HUMAN BONE MARROW STEM CELL DIFFERENTIATION TRAJECTORIES	1
3058 – METABOLIC HETEROGENEITY IN HEMATOPOIETIC STEM AND PROGENITOR CELLS FUELS INNATE IMMUNITY	1
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION	1
3044 – CRISPR ACTIVATION SCREENS IDENTIFY CO-DRIVERS OF MALIGNANT HAEMATOPOIESIS IN A DNMT3A MUTANT BACKGROUND	1
3090 – HEMATOPOIETIC STEM AND PROGENITOR CELL VESICLES PRE-CONDITION THE BONE MARROW NICHE DURING TRANSPLANTATION	1
3015 – COORDINATED REGULATION AT THE SYSTEMIC AND LOCAL LEVELS PLAYS A PIVOTAL ROLE IN DETERMINING HEMATOPOIETIC STEM CELL NUMBERS	1
3002 – DAMAGE-RESISTANT MYELOID-DERIVED SUPPRESSOR CELLS DRIVE THE RECOVERY AND REGENERATION OF THE BONE MARROW ENDOTHELIAL HEMATOPOIETIC NICHE BY ACTIVATING NOTCH SIGNALING	1
3044 – IP-10 LOSS MODULATES ERYTHROID CELL PRODUCTION IN MOUSE MODELS OF MYELOPROLIFERATIVE NEOPLASMS	1
3068 – CBX7 INHIBITORS BLOCK CELL PROLIFERATION AND INDUCE DIFFERENTIATION OF ACUTE MYELOID AND LYMPHOBLASTIC LEUKEMIA CELLS	1
Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why	1
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER	1
3167 – NOTCH3 C455R EXPRESSION IN THE MURINE HEMATOPOIETIC SYSTEM RESULTS IN CLONAL HAEMATOPOIESIS AND A PERTURBED INFLAMMATORY MILIEU	1
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM	1
3104 – FITNESS IS A BETTER PREDICTOR OF OUTCOMES IN CLONAL HEMOPOIESIS COMPARED TO CLONE SIZE	1
3099 – REGULATORY ROLE OF 3D DNA STRUCTURE IN HEMATOPOIESIS AND LEUKEMOGENESIS	1
2026 – A CANCER IMMUNOTHERAPY MODALITY BASED ON DENDRITIC CELL REPROGRAMMING IN VIVO	1
3128 – HYALURONIC ACID- GPRC5C SIGNALLING PROMOTES DORMANCY IN HEMATOPOIETIC STEM CELLS	1
Corrigendum to ‘3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME’ [	1
Balancing hematopoietic stem cell self-renewal and differentiation activities throughout ontogeny and aging	1
3084 – CELL QUIESCENCE AND REPROGRAMMING ARE DISTINCTIVE FEATURES OF PRE-LEUKEMIC STEM CELLS IN B-ACUTE LYMPHOBLASTIC LEUKEMIA	1
3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS	1
3201 – MOLECULAR CHARACTERISTICS OF MALIGNANT HEMATOPOIETIC STEM CELLS IN ESSENTIAL THROMBOCYTHEMIA ACROSS DISTINCT DRIVER MUTATIONS	1
2016 – METALLOPROTEINASE INHIBITION REDUCES AML GROWTH, PREVENTS STEM CELL LOSS, AND IMPROVES CHEMOTHERAPY EFFECTIVENESS	1
3062 – HIGH THROUGHPUT EPIGENOMIC PROFILING IN HEMATOPOIETIC STEM/PROGENITOR FATE COMMITMENT	1
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE	1
3125 – ANTIFUNGALS CLOTRIMAZOLE AND ECONAZOLE NITRATE EFFECTIVELY TARGET A METABOLIC VULNERABILITY OF PAEDIATRIC ACUTE MYELOID LEUKAEMIA (PAML) WITH CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN VITRO.	1
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS	1
3221 – NFAT TRANSCRIPTION FACTORS ARE REQUIRED FOR DEFINITIVE HEMATOPOIESIS	1
Cover 2: Editorial Board	1
3159 – A SINGLE-CELL PROTEIN-TRANSCRIPTOME ATLAS OF HAEMATOPOIESIS ACROSS THE HUMAN LIFESPAN	1
1019 –	1
3124 – GRANULOCYTE COLONY-STIMULATING FACTOR MODIFIES THE IN VITRO DIFFERENTIATION OF HUMAN PRIMITIVE ERYTHROID PROGENITOR CELLS	1
3202 – M. AVIUM INDUCES EPIGENETIC REPROGRAMMED HSPC-TRAINED IMMUNITY THAT ALTERS DOWNSTREAM MYELOID IMMUNE FUNCTION.	1
3055 – ENHANCING TRANSLATION FIDELITY EXTENDS HEMATOPOIETIC STEM CELL LONGEVITY	1
3103 – INHIBITING MAST CELL FUNCTION TO PROMOTE HEMATOPOIETIC REGENERATION FOLLOWING INJURY	1
3187 – IKAROS LOSS ENHANCES PRE-LEUKEMIC THYMOCYTE SELF-RENEWAL AND DRIVES T-ALL IN MICE	1
Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974–2003)	1
3158 – FUNCTIONAL POTENTIAL OF FETAL LIVER HEMATOPOIETIC STEM CELLS IS MAINTAINED BY JAGGED1 ACTIVATION OF NOTCH SINGALING	1
3002 – TRANSCRIPTION FACTOR PROFILING REVEALS THAT CEBPA PROMOTES RIBOSOMAL RNA SYNTHESIS IN MYELOID PROGENITORS	1
3175 – AN UNSUPERVISED INTEGRATION FRAMEWORK TO COMPREHENSIVELY CAPTURE HUMAN HEMATOPOIETIC STEM CELL VARIATION IDENTIFIES HALLMARK SIGNATURES WITH A LINK TO AGING	1
3020 – RNA-INTERFERENCE SCREEN IDENTIFIES MTA1 AS A REGULATOR OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS	1
3145 – WHAT IS THE FUNCTION OF THE EPO-EPOR AXIS IN MATURE XENOPUS ERYTHROCYTES?	1
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE	1
3086 – APOPTOTIC CELLS-DERIVED CD14(+) MICROPARTICLES PROMOTE THE PHAGOCYTIC ACTIVITY OF NEUTROPHILIC PRECURSOR CELLS IN THE PHAGOCYTOSIS OF APOPTOTIC CELLS	1
3004 – ACUTE MYELOID LEUKEMIA CELLS REQUIRE 18-CARBON LONG FATTY ACIDS FOR PROTEIN S-ACYLATION TO MAINTAIN MITOCHONDRIAL ACTIVITY AND METABOLIC PLASTICITY	1
3143 – ACUTE HEMATOPOIETIC RESPONSE OF GRANULOCYTE COLONY-STIMULATING FACTOR EXPRESSION IN MEDAKA FISH	1
3139 – DEFECTIVE MYELOID LINEAGE PRIMING AND GENOME INSTABILITY UNDERLIE MARROW FAILURE IN A ZEBRAFISH GATA2 DEFICIENCY MODEL	1
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation	1
3137 – A MODIFIED ACTIVIN RECEPTOR TYPE IIB LIGAND TRAP (RAP-536) IMPROVES ANEMIA IN SF3B1K700E MICE BY PROMOTING EARLY-STAGE ERYTHROPOIESIS AND IMPROVING ALTERNATIVE SPLICING	1
3126 – RUNX FACTORS REGULATE EX VIVO HAEMATOPOIETIC STEM CELL EXPANSION	1